| 000 | 01734 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250513174530.0 | ||
| 264 | 0 | _c19990413 | |
| 008 | 199904s 0 0 eng d | ||
| 022 | _a0160-6689 | ||
| 024 | 7 |
_a10.4088/jcp.v60n0303 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aStrober, M | |
| 245 | 0 | 0 |
_aThe pharmacotherapy of depressive illness in adolescents: an open-label comparison of fluoxetine with imipramine-treated historical controls. _h[electronic resource] |
| 260 |
_bThe Journal of clinical psychiatry _cMar 1999 |
||
| 300 |
_a164-9 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Comparative Study; Journal Article | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAge Factors |
| 650 | 0 | 4 |
_aAntidepressive Agents, Second-Generation _xtherapeutic use |
| 650 | 0 | 4 | _aCohort Studies |
| 650 | 0 | 4 |
_aDepressive Disorder _xdiagnosis |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFluoxetine _xtherapeutic use |
| 650 | 0 | 4 | _aHospitalization |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImipramine _xtherapeutic use |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aPatient Dropouts |
| 650 | 0 | 4 |
_aPsychiatric Status Rating Scales _xstatistics & numerical data |
| 650 | 0 | 4 |
_aSelective Serotonin Reuptake Inhibitors _xtherapeutic use |
| 650 | 0 | 4 | _aSeverity of Illness Index |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aDeAntonio, M | |
| 700 | 1 | _aSchmidt-Lackner, S | |
| 700 | 1 | _aPataki, C | |
| 700 | 1 | _aFreeman, R | |
| 700 | 1 | _aRigali, J | |
| 700 | 1 | _aRao, U | |
| 773 | 0 |
_tThe Journal of clinical psychiatry _gvol. 60 _gno. 3 _gp. 164-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.4088/jcp.v60n0303 _zAvailable from publisher's website |
| 999 |
_c10152025 _d10152025 |
||